Fox Run Management, L.L.C. Nevro Corp Transaction History

Fox Run Management, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$30.17 - $41.11 $467,514 - $637,040	-15,496 Reduced 57.47%	11,467 $414,000
Q4 2022 Feb 07, 2023	BUY	$36.43 - $49.4 $473,917 - $642,644	13,009 Added 93.23%	26,963 $1.07 Million
Q3 2022 Nov 07, 2022	BUY	$40.66 - $53.03 $567,369 - $739,980	13,954 New	13,954 $650,000
Q4 2020 Feb 08, 2021	SELL	$138.17 - $184.34 $305,493 - $407,575	-2,211 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$114.09 - $145.51 $252,252 - $321,722	2,211 New	2,211 $308,000
Q4 2018 Jan 15, 2019	SELL	$35.43 - $56.29 $410,173 - $651,669	-11,577 Closed	0 $0
Q3 2018 Oct 05, 2018	BUY	$44.22 - $75.47 $511,934 - $873,716	11,577 New	11,577 $660,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.